Bringing science into pharmaceutical practice
If you would like to find more about Hovione's full range of inhalation drug development services, particle engineering and development by design schedule a meeting with us.
Celebrating our 60th Anniversary
We are proud to be a B Corporation.
Macau News Agency, January 25, 2019
Hovione has issued a bond of $50 million US dollars maturing in 2033.
We’d welcome your feedback!
Thank you for visiting our website.
Would you like to take a few minutes to complete our short survey to let us know how we can improve your experience?